Frost & Sullivan's Award underlined Mindray's Innovative practice

2010-11-19

n0-s0

SHENZHEN, China, Nov.22--Frost & Sullivan "Growth • Innovation • Leadership" summit was successfully held on Tuesday 9th November, 2010, in Shanghai, China. Two hundred business leaders and industry elites from healthcare, industrial automation, chemical, telecommunications, automotive industries attended the summit. Frost & Sullivan Excellence in Best Practices Awards Banquet took place the same day. The Excellence in Innovation Award was presented to Shenzhen Mindray Bio-medical Electronic Co., LTD ("Mindray"). This award recognized Mindray's innovative performance in products and services, as well as its dedication to becoming a leading medical equipment supplier.

 

Mindray, based in Shenzhen, China, was founded in 1991. The company's success has been built on innovation in the past 20 years. Started as a supplier of patient monitors, the company gradually expanded its business to in-vitro diagnostics, ultrasound, radiographic equipment and ICU/OR overall solution etc. In 2010, the company received China Food and Drug Administration approval to launch its BeneHeart D6 biphasic defibrillator, which made Mindray the first domestic medical equipment enterprise to manufacture such product. Compared with some foreign brand machines in the market, Mindray's BeneHeart D6 biphasic defibrillator is reliable, user friendly, and equipped with innovative data transmission systems and multi-parameter monitoring functions.

 

Report from Frost & Sullivan indicates, besides its competitive technologies, Mindray also excels in both product line planning and marketing methods innovation. Mindray's growth strategies have resulted in outstanding sales performance in both urban and rural health care markets in China, as well as countries overseas.